![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 07, 2016 2:41:51 PM
The company relies too much on moving forward with Aspire and their shelf registry. Now with 3 potential blockbuster how are you going to pay for it all? At this point simply announcing new trials like B-UP only exasperates their financial conditions or those investors that worry about such, down ~5 million on the last 10Q. The market has the stock locked in under $2 and the only current forward path is dilute, dilute at these prices.
I like Cellceutix management team but the only clinical trial experience they have is at this particular company and the road forward with the FDA does not get easier. They have been adding some experience in to the mix, Dr. Trust etc for Brilacidin phase 3 but they need to add across the board.
Getting an experienced partner with Brilacidin, Kevetrin or Prurisol is much needed at this point and none of these drugs should be off the negotiation table. Polymed failed with a great antibiotic drug a lot of arrogance and no funds!
I can see the forest for the trees and it not a matter of patience anymore. Just announcing great trial results is not enough -GET A PARTNER gain financing and experience..Cellceutix -GET OUT OF THE BOX you put yourself in!
IMO =-)
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • Sep 4, 2024 9:02 AM
FEATURED Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • Sep 4, 2024 8:45 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM